Review Article

Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies

Table 1

Concentrations of adiponectin and bone mineral density in men and women.

Characteristics of the respondentsMean ± SD or median (range) Author
Age
(years)
BMI
(kg/m2)
Fat-free mass (kg)Spine BMD
(g/cm2)
Total BMD
(g/cm2)
Adiponectin
( g/mL)

MaleHemodialysis patients (%) 17.7 (3.1–71.5)Okuno et al. (2012) [52]
nondiabetic Zillikens et al. (2010) [53]

Female Total
(pre- and postmenopausal)
adult Zillikens et al. (2010) [53]
adult J. Jürimäe and T. Jürimäe (2007) [51]
adult 8.3 (3.9)Richards et al. (2007) [54]
Premenopausal adult J. Jürimäe and T. Jürimäe (2007) [51]
middle-age J. Jürimäe and T. Jürimäe (2007) [51]
adult Kontogianni et al. (2004) [55]
adolescents Huang et al. (2004) [56]
Postmenopausal non-diabetic
(with hip fracture)
nonosteoporosis Özkurt (2009) [26]
osteoporosis
Total
Postmenopausal 52.529.40.88913.25Ağbaht et al. (2009) [12]
middle-age J. Jürimäe and T. Jürimäe (2007) [51]
older
Kontogianni et al. (2004) [55]

Male & Female
(nondiabetic)
Nonosteoporotic Mohiti-Ardekani et al. (2013) [57]
Osteoporotic